Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jun;106(2):367–372. doi: 10.1111/j.1476-5381.1992.tb14342.x

Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.

S Zeman 1, D Lodge 1
PMCID: PMC1907489  PMID: 1382781

Abstract

1. A grease-gap technique was used to record depolarizing responses to alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate (AMPA), kainate and N-methyl-D-aspartate (NMDA) in the hemisected spinal cord of the neonatal rat. The pharmacology of non-NMDA subtypes of glutamate receptor was investigated with the novel quinoxalinedione, 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo (F)-quinoxaline (NBQX) and with a series of barbiturates. 2. NBQX antagonized AMPA- and kainate-, but not NMDA- induced depolarizations. The near parallel shifts of the major part of the dose-response curves for AMPA and kainate by NBQX gave pA2 values (+/- s.e.) of 6.7 +/- 0.2 and 6.8 +/- 0.2 respectively, consistent with a common site of action for these two agonists. 3. Below the 50% level at which these pA2 values were calculated, however, an NBQX-resistant plateau was seen within the kainate, but not the AMPA, dose-response curve. 4. In decreasing order of potency, methohexitone, secobarbitone, thiopentone, pentobarbitone and phenobarbitone preferentially reduced kainate-, rather than AMPA- and NMDA-, induced depolarizations. Methohexitone was also the most selective with IC50S against kainate, AMPA and NMDA of 31 +/- 7, 172 +/- 47 and greater than 200 microM respectively. 5. The NBQX-resistant plateau seen within the kainate dose-response curve was reduced by methohexitone. Kainate antagonism by methohexitone was not reduced by 50 microM picrotoxin. 6. We conclude that, while mixed agonist actions may hamper demonstration of antagonist selectivity, depolarizations induced by the non-NMDA ionotropic agonists, AMPA and kainate, are mediated in part via distinct receptors.

Full text

PDF
367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal S. G., Evans R. H. The primary afferent depolarizing action of kainate in the rat. Br J Pharmacol. 1986 Feb;87(2):345–355. doi: 10.1111/j.1476-5381.1986.tb10823.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Birch P. J., Grossman C. J., Hayes A. G. 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol. 1988 Oct 26;156(1):177–180. doi: 10.1016/0014-2999(88)90163-x. [DOI] [PubMed] [Google Scholar]
  3. Campochiaro P., Coyle J. T. Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation. Proc Natl Acad Sci U S A. 1978 Apr;75(4):2025–2029. doi: 10.1073/pnas.75.4.2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Collins G. G., Anson J., Surtees L. Presynaptic kainate and N-methyl-D-aspartate receptors regulate excitatory amino acid release in the olfactory cortex. Brain Res. 1983 Apr 11;265(1):157–159. doi: 10.1016/0006-8993(83)91348-3. [DOI] [PubMed] [Google Scholar]
  5. Cutler R. W., Young J. Effect of barbiturates on release endogenous amino acids from rat cortex slices. Neurochem Res. 1979 Jun;4(3):319–329. doi: 10.1007/BF00963802. [DOI] [PubMed] [Google Scholar]
  6. Davies J., Watkins J. C. Depressant actions of gamma-D-glutamylaminomethyl sulfonate (GAMS) on amino acid-induced and synaptic excitation in the cat spinal cord. Brain Res. 1985 Feb 18;327(1-2):113–120. doi: 10.1016/0006-8993(85)91505-7. [DOI] [PubMed] [Google Scholar]
  7. Dingledine R. New wave of non-NMDA excitatory amino acid receptors. Trends Pharmacol Sci. 1991 Oct;12(10):360–362. doi: 10.1016/0165-6147(91)90602-o. [DOI] [PubMed] [Google Scholar]
  8. Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature. 1991 Jun 27;351(6329):745–748. doi: 10.1038/351745a0. [DOI] [PubMed] [Google Scholar]
  9. Evans R. H. The effects of amino acids and antagonists on the isolated hemisected spinal cord of the immature rat. Br J Pharmacol. 1978 Feb;62(2):171–176. doi: 10.1111/j.1476-5381.1978.tb08442.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fletcher E. J., Martin D., Aram J. A., Lodge D., Honoré T. Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro. Br J Pharmacol. 1988 Oct;95(2):585–597. doi: 10.1111/j.1476-5381.1988.tb11680.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Foster A. C., Fagg G. E. Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors. Brain Res. 1984 May;319(2):103–164. doi: 10.1016/0165-0173(84)90020-1. [DOI] [PubMed] [Google Scholar]
  12. Frandsen A., Quistorff B., Schousboe A. Phenobarbital protects cerebral cortex neurones against toxicity induced by kainate but not by other excitatory amino acids. Neurosci Lett. 1990 Mar 26;111(1-2):233–238. doi: 10.1016/0304-3940(90)90374-i. [DOI] [PubMed] [Google Scholar]
  13. Gallo V., Giovannini C., Levi G. Modulation of non-N-methyl-D-aspartate receptors in cultured cerebellar granule cells. J Neurochem. 1990 May;54(5):1619–1625. doi: 10.1111/j.1471-4159.1990.tb01213.x. [DOI] [PubMed] [Google Scholar]
  14. Greenamyre J. T., Young A. B., Penney J. B. Quantitative autoradiography of L-[3H]glutamate binding to rat brain. Neurosci Lett. 1983 Jun 16;37(2):155–160. doi: 10.1016/0304-3940(83)90146-5. [DOI] [PubMed] [Google Scholar]
  15. Harrison N. L., Simmonds M. A. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381–391. doi: 10.1111/j.1476-5381.1985.tb12922.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hollmann M., O'Shea-Greenfield A., Rogers S. W., Heinemann S. Cloning by functional expression of a member of the glutamate receptor family. Nature. 1989 Dec 7;342(6250):643–648. doi: 10.1038/342643a0. [DOI] [PubMed] [Google Scholar]
  17. Honoré T., Davies S. N., Drejer J., Fletcher E. J., Jacobsen P., Lodge D., Nielsen F. E. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science. 1988 Aug 5;241(4866):701–703. doi: 10.1126/science.2899909. [DOI] [PubMed] [Google Scholar]
  18. Iino M., Ozawa S., Tsuzuki K. Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J Physiol. 1990 May;424:151–165. doi: 10.1113/jphysiol.1990.sp018060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Keinänen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T. A., Sakmann B., Seeburg P. H. A family of AMPA-selective glutamate receptors. Science. 1990 Aug 3;249(4968):556–560. doi: 10.1126/science.2166337. [DOI] [PubMed] [Google Scholar]
  20. Kiskin N. I., Krishtal O. A., Tsyndrenko AYa Excitatory amino acid receptors in hippocampal neurons: kainate fails to desensitize them. Neurosci Lett. 1986 Jan 30;63(3):225–230. doi: 10.1016/0304-3940(86)90360-5. [DOI] [PubMed] [Google Scholar]
  21. Kiskin N. I., Krishtal O. A., Tsyndrenko A. Ya. Cross-desensitization Reveals Pharmacological Specificity of Excitatory Amino Acid Receptors in Isolated Hippocampal Neurons. Eur J Neurosci. 1990;2(5):461–470. doi: 10.1111/j.1460-9568.1990.tb00437.x. [DOI] [PubMed] [Google Scholar]
  22. Krogsgaard-Larsen P., Honoré T., Hansen J. J., Curtis D. R., Lodge D. New class of glutamate agonist structurally related to ibotenic acid. Nature. 1980 Mar 6;284(5751):64–66. doi: 10.1038/284064a0. [DOI] [PubMed] [Google Scholar]
  23. Lodge D., Jones M. G., Palmer A. J. Excitatory amino acids: new tools for old stories or pharmacological subtypes of glutamate receptors: electrophysiological studies. Can J Physiol Pharmacol. 1991 Jul;69(7):1123–1128. doi: 10.1139/y91-164. [DOI] [PubMed] [Google Scholar]
  24. Mayer M. L., Westbrook G. L. The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol. 1987;28(3):197–276. doi: 10.1016/0301-0082(87)90011-6. [DOI] [PubMed] [Google Scholar]
  25. McLennan H., Liu J. The action of six antagonists of the excitatory amino acids on neurones of the rat spinal cord. Exp Brain Res. 1982;45(1-2):151–156. doi: 10.1007/BF00235774. [DOI] [PubMed] [Google Scholar]
  26. Monaghan D. T., Bridges R. J., Cotman C. W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol. 1989;29:365–402. doi: 10.1146/annurev.pa.29.040189.002053. [DOI] [PubMed] [Google Scholar]
  27. Monaghan D. T., Holets V. R., Toy D. W., Cotman C. W. Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature. 1983 Nov 10;306(5939):176–179. doi: 10.1038/306176a0. [DOI] [PubMed] [Google Scholar]
  28. Okazaki M. M., Nadler J. V. Protective effects of mossy fiber lesions against kainic acid-induced seizures and neuronal degeneration. Neuroscience. 1988 Sep;26(3):763–781. doi: 10.1016/0306-4522(88)90097-8. [DOI] [PubMed] [Google Scholar]
  29. Olney J. W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969 May 9;164(3880):719–721. doi: 10.1126/science.164.3880.719. [DOI] [PubMed] [Google Scholar]
  30. Patneau D. K., Mayer M. L. Kinetic analysis of interactions between kainate and AMPA: evidence for activation of a single receptor in mouse hippocampal neurons. Neuron. 1991 May;6(5):785–798. doi: 10.1016/0896-6273(91)90175-y. [DOI] [PubMed] [Google Scholar]
  31. Pin J. P., Van Vliet B. J., Bockaert J. Complex interaction between quisqualate and kainate receptors as revealed by measurement of GABA release from striatal neurons in primary culture. Eur J Pharmacol. 1989 Mar 7;172(1):81–91. doi: 10.1016/0922-4106(89)90047-3. [DOI] [PubMed] [Google Scholar]
  32. Potashner S. J., Gerard D. Kainate-enhanced release of D-[3H]aspartate from cerebral cortex and striatum: reversal by baclofen and pentobarbital. J Neurochem. 1983 Jun;40(6):1548–1557. doi: 10.1111/j.1471-4159.1983.tb08125.x. [DOI] [PubMed] [Google Scholar]
  33. Sheardown M. J., Nielsen E. O., Hansen A. J., Jacobsen P., Honoré T. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science. 1990 Feb 2;247(4942):571–574. doi: 10.1126/science.2154034. [DOI] [PubMed] [Google Scholar]
  34. Stone T. W. Sensitivity of hippocampal neurones to kainic acid, and antagonism by kynurenate. Br J Pharmacol. 1990 Dec;101(4):847–852. doi: 10.1111/j.1476-5381.1990.tb14169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stone W. E., Javid M. J. Effects of anticonvulsants and glutamate antagonists on the convulsive action of kainic acid. Arch Int Pharmacodyn Ther. 1980 Jan;243(1):56–65. [PubMed] [Google Scholar]
  36. Teichberg V. I., Eshhar N., Maoz I., Mano I., Ornstein D., Ortega A., Gregor P. Molecular characterization, ultrastructural localization and gene cloning of the chick cerebellar kainate receptor. Adv Exp Med Biol. 1990;268:73–78. doi: 10.1007/978-1-4684-5769-8_9. [DOI] [PubMed] [Google Scholar]
  37. Teichberg V. I., Tal N., Goldberg O., Luini A. Barbiturates, alcohols and the CNS excitatory neurotransmission: specific effects on the kainate and quisqualate receptors. Brain Res. 1984 Jan 23;291(2):285–292. doi: 10.1016/0006-8993(84)91260-5. [DOI] [PubMed] [Google Scholar]
  38. Turski L., Niemann W., Stephens D. N. Differential effects of antiepileptic drugs and beta-carbolines on seizures induced by excitatory amino acids. Neuroscience. 1990;39(3):799–807. doi: 10.1016/0306-4522(90)90262-3. [DOI] [PubMed] [Google Scholar]
  39. Watkins J. C., Evans R. H. Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol. 1981;21:165–204. doi: 10.1146/annurev.pa.21.040181.001121. [DOI] [PubMed] [Google Scholar]
  40. Watkins J. C., Pook P. C., Sunter D. C., Davies J., Honore T. Experiments with kainate and quisqualate agonists and antagonists in relation to the sub-classification of 'non-NMDA' receptors. Adv Exp Med Biol. 1990;268:49–55. doi: 10.1007/978-1-4684-5769-8_6. [DOI] [PubMed] [Google Scholar]
  41. Weakly J. N. Effect of barbiturates on 'quantal' synaptic transmission in spinal motoneurones. J Physiol. 1969 Sep;204(1):63–77. doi: 10.1113/jphysiol.1969.sp008898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wyllie D. J., Mathie A., Symonds C. J., Cull-Candy S. G. Activation of glutamate receptors and glutamate uptake in identified macroglial cells in rat cerebellar cultures. J Physiol. 1991 Jan;432:235–258. doi: 10.1113/jphysiol.1991.sp018383. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES